Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Enhanced Stability : Freeze-dried formulation maintains peptide integrity during storage and transport, with protective packaging in sealed, research-grade vials designed to preserve sterility and purity
While animal studies suggest a favorable safety profile, comprehensive human safety data is lacking
GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration
A lyophilized vial stored cold and away from light remains stable for substantially longer than a pre-mixed solution
Risk Note: For example, Infusion studies in fetal sheep models found that high doses of IGF-1 LR3 were found to induced severe hypoglycemia and hypoxemia
US$ 28.21
US$ 24.35
US$ 23.24
US$ 20.69
US$ 21.03
US$ 29.19
US$ 26.95
